Specific antitumour vaccine for renal cancer
- PMID: 14987879
- DOI: 10.1016/S0140-6736(04)15625-0
Specific antitumour vaccine for renal cancer
Comment on
-
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial.Lancet. 2004 Feb 21;363(9409):594-9. doi: 10.1016/S0140-6736(04)15590-6. Lancet. 2004. PMID: 14987883 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
